I believe in making it very difficult for people to refuse vaccines. There’s enough of the libertarian about me that I wouldn’t actually strap them down and inject them, but I’m fine with school districts making parents write out their conscientious objections to children being immunised or with sports clubs requiring adult proof of immunisation before people can join. What I or you think is, though, beside the point. Much of the US is walking away from cajoling and compulsion and there’s great pressure in Europe for similar change. We can either go on moaning about how we wish the world hadn’t changed or we can respond effectively.

Before the current US Administration began rewriting vaccine recommendations, one in six US parents wasn’t following them. We used to joke that vaccine-preventable diseases in the West had become diseases of children of the over-educated middle classes who shopped at Whole Foods and did naked yoga classes; vaccine refusers now are still more likely to be white, but they skew to being conservative, very religious, and young. Recommendations actually reduced uptake in this group because most have a deep distrust of the Federal Government and its agencies.

Formal vaccine refusals in Poland more than doubled from 2017 to 2022 and reached over 87,000 in 2023, a 1685% increase since 2003; measles cases surged 10x in early 2024 due to falling rates. Ireland, where I live, has the third-lowest childhood vaccine coverage rate in the OECD.

There are bright spots too, Italy for example, and the battle is far from lost. But the mistrust now endemic to the United States is coming to Europe.

High-handed US and European experts

You can understand confusion, if not mistrust. About half of parents in the USA did not vaccinate their children for flu in the past year, compared with 41 percent who said they had done so, a Washington Post / Kaiser Family Fund poll found. Coverage started declining after 2019. In 2016, the US CDC said that the nasal flu vaccine used in children provided “no measurable benefit” (injectable vaccines for adults were, as usual, highly effective). In the same year, Public Health England said that the same vaccine (produced by a British company in a British factory) was 58 percent effective. Canada followed the UK, saying that its population was very different to the USA! It’s very unlikely that both the Americans and the Canadians were right — despite those obvious population differences…. Few journalists covered the story — I suspect because no-one wanted to be accused of promoting vaccine scepticism. The vaccine is now recommended again in the USA.

Few American paediatricians and even fewer nurses would have been able to explain this to parents because no-one ever bothered to give the professionals an explanation. What do we think doctors told parents who asked why a vaccination was recommended then was not and then was again? British parents who did a web search (this was pre-Chat GPT, remember) might have asked why their children were getting an apparently ineffective vaccine and would have met equally bemused stares from their health providers. Did anyone brief social media influencers or health journalists? Of course not, who do they think they are? What impudence…

I know some of those involved and I’m sure that there was no subterfuge and nothing sinister going on; the answer is likely to be dull and involve methodology and surveillance systems.

This is the way we all used to approach treatment discussions 40 years ago — the doctor told you what to do, you thanked him (it was nearly always a him) and you did it. Questions were a sign of disrespect, of even psychological illness. I was recently treated by a Russian dentist, now practising in Ireland, who was shocked and outraged when I questioned his recommendation to use antibiotics prophylactically; if he had been Irish, he would have been completely used to it.

Nonsensical recommendations in developing countries

Vaccine hesitancy looks a bit different in France. Those least likely to have their children vaccinated tend to be more educated, high users of the internet for information and to have lower trust in health authorities. Those who refuse vaccines for themselves tend to be at the lower end of the social hierarchy with less education and fewer financial resources. Many are ​immigrants and descendants of immigrants, and residents of French overseas departments. Both are probably likely to know about the vaccines which Western experts recommend for children in the developing world, including in Francophone countries.

I remember doing a policy interview with the health minister of a large Indian state. I was trying to find out what he might pay for an effective TB vaccine. “But”, he said, “we already have a TB vaccine. Why do I need a new one?” His top civil servant was sitting behind him and frantically gesticulating to me to try to stop me explaining that the BCG vaccine, given to almost every Indian newborn, may do nothing to prevent TB infections and, at best, may make the disease less severe in some of the children who contract it. It is, though, very good at causing severe side effects. No developed economy uses it; almost every poor one does.

I’m ashamed to say that I did not explain BCG as clearly as I should have to the minister. He was the norm, not the exception, in that series of policymaker interviews: few of those making decisions about TB vaccine policy had ever been given a thorough, honest briefing about the limitations of the vaccines their expert advisers recommended. None of the parents, of course, were ever told about any of these reservations.

There might also be a case for the current practice of giving many children in Africa and Asia a vaccine that sometimes causes polio, instead of preventing it, although I doubt it. The risks of a child contracting polio from the live-attenuated oral vaccine are probably underestimated when they’re presented to politicians and policy influencers. Hardly any parents who bring their children forward for these vaccines are told about the risk or the rationale for continuing to use them, rather than the perfectly safe inactivated vaccine used throughout the rich world.

Is it any wonder that those with insight into the developing world are sceptical? The real wonder is that vaccine confidence is still so high in Africa and Asia. That probably comes from everyday encounters with the tragic consequences of infection by vaccine-preventable illnesses, an experience blessedly denied to most Americans and Europeans.

What we need to do now

The road ahead has been cleared for us. Thirty years ago, I went out with a trainee doctor at the Royal College of Surgeons in Ireland. He was upset one evening because he had been berated by his tutor for telling an older patient that she had cancer — it had been agreed with the family that she would be told that she had a “growth” to avoid upsetting her. At least she found out: King George VI of the United Kingdom sent his daughter, Princess Elizabeth, on a world tour in 1952 because neither he nor she had been told that he had lung cancer and that it was terminal. He never saw her again. These stories shock us now because honesty, realism and communication are taken for granted in what we tell patients who are ill. These principles need to be the new basis for what we tell people who are healthy and want to stay that way.

First we need a change in attitude. Whether to be immunised or not is a decision that people will take — actually, a series of decisions. We don’t need to think about whether we like the concept or not, it is the way things increasingly are. We have to get ordinary people used to making good decisions, just as they do about other life issues such as house buying or insurance or continuing education. Ordinary people are not property experts or risk analysts or trained evaluators of course offerings, but they mostly make reasonable choices. They can do the same thing with vaccines.

Then, we need to communicate much more. Vaccine producers are free to talk to the public about recommended vaccines in many countries; where they are not, they need to be allowed to. Then they need to accept their responsibility to speak often, clearly and loudly. They are the experts on the vaccines they produce and they must tell potential recipients or the parents of recipients about the benefits and disadvantages. Of course, they need to do it in an honest and balanced way. They will be more successful if they communicate in partnership with professional organisations, charities and respected consumer groups. They can be transparent: they have a commercial interest in getting people to accept vaccines but a legal responsibility to set out all the factors in deciding whether to or not. It’s like banks selling mortgages and car dealerships selling warranties.

Researchers and healthcare providers need training in communication and answering questions. They need to be much better at helping policy makers to make decisions about vaccines. Today, too few vaccines are reimbursed and many are offered only to some of those who would benefit from them. In many countries, it is still too hard to get vaccinated and even where rules have changed, practices have not — look at Poland, for example. Politicians and public officials can unleash vaccines so that they can do even more to boost productivity, growth and wealth in society.

Those same scientific and medical experts need to be much better at talking to people who are making decisions about immunisation. Research tells us clearly what helps the right decision, but too few professionals follow the evidence. The most powerful prompt to action is a trusted health professional saying, “I would like you to do this”. Setting a good example works wonders too, but too few health professionals have had all of the vaccines recommended for them.Communication can change all of this.

The vast majority of social media influencers want to give good advice and powerful motivation but no-one talks to them — after all, we want people to follow the guidelines, not think, don’t we? For example, have you seen Dr Mike Varshavski take on 20 vaccine sceptics at once? Thirty million people probably have over various platforms and he’s brilliant. Industry and professionals need to work with influencers who specialise in women’s issues, childhood, workplace effectiveness and, of course, health. Look at this from Dr Ahmed Ezzat — his videos on RSV reduced calls to the emergency services by 25% — and just think what he can do for vaccines.

Journalists are discouraged from writing pieces about vaccine decisions — “just tell people to follow expert recommendations”. Many, consequently, avoid writing about vaccines. We need to treat these journalists as powerful allies in helping lay people to make important decisions with lifelong implications for their risk of developing chronic illnesses. It’s the way that property developers treat journalists who write about houses,

Honestly, I still think it would be simpler and still ethically correct to just nudge almost everyone into getting immunised but that is not an option in many places now and, given the global market in ideas, won’t be one anywhere soon.

Parents get things right

Asia should encourage us. Many parents save and spend to get their children the best vaccines. The state often provides old tech or nothing, so middle-class parents take their children to private clinics for the best protection and pay full price for it. Of course, it’s not fair to poorer children and it is crazy public policy given that population sizes will plunge across Asia over the next 30 years so every child, whether middle class or not, is a precious national resource. Still, it shows that individual families can and do make better decisions than health policy makers when the routes of communication are open and used well.

The post We Have to Earn Better Vaccine Coverage Rates appeared first on Medika Life.

Conflicts compound these inequities. Fragile and conflict-afflicted countries account for just a quarter of the world’s infants, yet they harbour half of all zero-dose children, whose numbers have increased from 3.6 million in 2019 to 5.4 million in 2024. In Sudan, vaccination coverage collapsed — from 85% pre-war to as low as 8% in conflict zones — while Yemen’s zero-dose figures climbed significantly, driven by instability, health service disruptions, and misinformation.

Conversely, Gavi-supported, low-income countries saw marked improvements, reducing un- and under-vaccinated cohorts by around 650,000 in 2024. Yet even high- and upper-middle-income economies are experiencing slippage, with measles coverage hovering at 84% (first dose) and 76% (second), below the 95% threshold needed for herd immunity. Consequently, measles outbreaks surged, with 60 countries reporting significant incidents in 2024, doubling since 2022.

Country case snapshots powerfully illustrate these trends. In Bosnia and Herzegovina, measles vaccination rates are at just 55%, compared to Croatia’s 90%, contributing to over 7,000 cases and two adolescent deaths, prompting WHO and UNICEF to urge intensified immunisation campaigns. In Pakistan, polio resurgence has occurred amid militant threats and disrupted campaigns, with over one million children missing doses in 2024. The government’s response includes large-scale vaccination drives and policy enforcement, such as arrest warrants, signalling both the challenge and political recognition of routine immunisation’s fragility. Meanwhile, Bangladesh has steadily expanded its vaccine schedule — adding Hib, rubella, PCV, IPV and MR2 — achieving DTP3 coverage around 93% and fully vaccinated rates near 84% by 2019.

These illustrations reveal both progress and vulnerability. Countries with strong political will, robust systems, and community trust — like Bangladesh — are managing gains. Others, like Pakistan and Bosnia, highlight how instability, mistrust, and misinformation can swiftly unravel public health gains.

The 2024 immunisation data reiterates an urgent message. Global coverage has stabilised and broadened, but millions of children remain vulnerable in conflict zones and complacent high-income settings. Measles outbreaks, polio flare-ups, diphtheria spikes, and new threats like RSV underscore that the progress we’ve made is neither permanent nor evenly shared. Unless we decisively fill funding gaps, fortify health delivery in emergencies, ensure vaccine equity, and strengthen trust, these vulnerabilities will deepen — and outbreaks will follow.

The post Global childhood vaccination remains resilient, but equity cracks are widening appeared first on Medika Life.

Conflicts compound these inequities. Fragile and conflict-afflicted countries account for just a quarter of the world’s infants, yet they harbour half of all zero-dose children, whose numbers have increased from 3.6 million in 2019 to 5.4 million in 2024. In Sudan, vaccination coverage collapsed — from 85% pre-war to as low as 8% in conflict zones — while Yemen’s zero-dose figures climbed significantly, driven by instability, health service disruptions, and misinformation.

Conversely, Gavi-supported, low-income countries saw marked improvements, reducing un- and under-vaccinated cohorts by around 650,000 in 2024. Yet even high- and upper-middle-income economies are experiencing slippage, with measles coverage hovering at 84% (first dose) and 76% (second), below the 95% threshold needed for herd immunity. Consequently, measles outbreaks surged, with 60 countries reporting significant incidents in 2024, doubling since 2022.

Country case snapshots powerfully illustrate these trends. In Bosnia and Herzegovina, measles vaccination rates are at just 55%, compared to Croatia’s 90%, contributing to over 7,000 cases and two adolescent deaths, prompting WHO and UNICEF to urge intensified immunisation campaigns. In Pakistan, polio resurgence has occurred amid militant threats and disrupted campaigns, with over one million children missing doses in 2024. The government’s response includes large-scale vaccination drives and policy enforcement, such as arrest warrants, signalling both the challenge and political recognition of routine immunisation’s fragility. Meanwhile, Bangladesh has steadily expanded its vaccine schedule — adding Hib, rubella, PCV, IPV and MR2 — achieving DTP3 coverage around 93% and fully vaccinated rates near 84% by 2019.

These illustrations reveal both progress and vulnerability. Countries with strong political will, robust systems, and community trust — like Bangladesh — are managing gains. Others, like Pakistan and Bosnia, highlight how instability, mistrust, and misinformation can swiftly unravel public health gains.

The 2024 immunisation data reiterates an urgent message. Global coverage has stabilised and broadened, but millions of children remain vulnerable in conflict zones and complacent high-income settings. Measles outbreaks, polio flare-ups, diphtheria spikes, and new threats like RSV underscore that the progress we’ve made is neither permanent nor evenly shared. Unless we decisively fill funding gaps, fortify health delivery in emergencies, ensure vaccine equity, and strengthen trust, these vulnerabilities will deepen — and outbreaks will follow.

The post Global childhood vaccination remains resilient, but equity cracks are widening appeared first on Medika Life.

Yet today, we find ourselves dismantling these hard-won achievements. Extraordinary cuts to disease prevention, research, and surveillance programs signal a large-scale reversal of a successful strategy of containment and elimination. Such an irresponsible pivot risks opening the door for vaccine-preventable diseases, drug-resistant infections and new pandemics to reemerge with devastating force. If we continue down this path, the consequences will be felt not just in developing nations, but across the industrialized world, where health systems already are under strain.

It could take years to regain the high ground we currently hold against infectious diseases; many countries may never get there again. While pursuing modernization and efficiencies in the global health system is vital, randomly eliminating or suppressing funding and institutions we rely on to develop the pipeline of new vaccines, therapeutics, and practices to fight tomorrow’s pathogens only weakens us further. Our most dangerous disease threats constantly evolve, probe our weaknesses, and exploit natural opportunities to strike.

The attack on America’s preeminent medical research institutions and the innovations they fuel severely undermines our ability to counter disease while degrading the very talent we need to protect us: the next generation of scientists and medical researchers.

Many prominent health leaders are sounding the alarm, but until a coalition of the informed begins to take shape, we may as well be screaming into the wind. Unless a concerted effort is made to change course, the infrastructure, jobs, institutional knowledge, and recruitment of future health experts that constitute one of humanity’s greatest achievements may be dismantled. Surely by now we have learned that research and disease prevention is dramatically less costly than deploying the vast resources necessary to respond to a new outbreak.

Here’s one path forward: U.S. health communicators, advocates, and leaders should coordinate framing the issues to state and congressional lawmakers who stand to lose the most from the current health funding policy direction. Many of the places contributing the most to America’s competitive advantage in biomedical research are in conservative districts that receive funding from the NIH and other public sources.

Similarly, emerging diseases often pose the highest threat to people battling chronic diseases or living in areas underserved by health services, which means all of us are affected, regardless of economic status or ideological belief. People at every level of the health system—from practitioners to patients, researchers to drugmakers—should be energized to speak with one voice and let policymakers know that retreat in the face of defeatable disease threats is the wrong direction for the U.S.

Disease is humanity’s greatest enemy, and it constantly hovers at our doorstep. Do we pretend not to hear it knocking, or do we recognize its dangers and act?

That’s exactly the moment we are facing now. Our situation is complicated by the fact that our most important defenses – biomedical research and disease prevention infrastructure – are being demolished before our eyes. It will take real courage to act, but we must marshal our resources, defying the ambivalence and dismissiveness that make us more vulnerable to looming infectious disease threats. This is no time to retreat.

The post A Turning Point for Global Health appeared first on Medika Life.

Founded in 1948, WHO is a United Nations agency whose charter is to plan and coordinate the international response to health emergencies and help countries monitor, prepare for, and recover from disease threats. 

While not without controversy, WHO is the single best forum for predicting and planning for events affecting the health of humans across the planet.

Media coverage of the US withdrawal has focused on political rancor (Trump believes WHO mishandled the pandemic) and funding (While the US is one of 194 participating countries, it funds almost 20% of the agency’s $6.8 billion budget).[i]

As the new Administration gives up America’s seat for global health planning, its important to shine a light on real issues impacting Americans’ health and well-being. They are worth public scrutiny and debate, starting with this statement:

America is a First-World Nation Battling its Own Third-World Health Crises

America’s health care system is the most expensive in the world. It’s staffed with some of the world’s best health and medical talent. Despite this, we are at the bottom of the list in overall health compared to all developed nations. This includes access to care, administrative efficiency, equity, and health care outcomes. ^[ii]

• Americans are among the least healthy people in the rich world and among the most likely to die early.
• The richest men in America live longer than the average man in any country. The poorest have life expectancies comparable to men in Sudan and Pakistan.[iii] 
• If you are a citizen of Mississippi, you probably won’t live as long as someone from Bangladesh. [iv] [v] [vi]

• Maternal mortality rates for American women are worse than in most third-world countries. Even more unexplainable is that Black women are three times more likely to die of childbirth than White women. This gap is worse today than it was when we began keeping records in the early 1900’s.[vii] 
• America is a global leader in avoidable amputations. This is mainly due to the improper management of diabetes, which impacts 38.4 million Americans.[viii]
• 30 million Americans die prematurely each year from preventable diseases. Twenty-seven percent of US health-care spending goes to managing health conditions that are preventable.[ix]

As the World Health Organization focuses on increasing its investments in global Public Health, it’s important to note that America’s investment in similar Public Health services is declining.

Winston Churchill once said, “Healthy citizens are the greatest asset any country can have.”  And so, as we discuss and debate America’s role in creating a healthier world through organizations like WHO, let us actively debate and decide what priorities we will invest in to improve the health of the 330 million people who call America home.

[i] https://www.msn.com/en-us/politics/government/what-is-the-world-health-organization-and-why-does-trump-want-to-leave-it/ar-AA1xFf0l?ocid=BingNewsSerp

[ii]Mirror, Mirror 2024: A Portrait of the Failing U.S. Health System,  Commonwealth Fund, September, 2023, https://www.commonwealthfund.org/publications/fund-reports/2024/sep/mirror-mirror-2024

[iii] Raj Chetty, Michael Stepner, Sarah Abraham, Shelby Lin, Benjamin Scuderi, Nicholas Turner, Augustin Bergeron, and David Cutler,  Income and Life Expectancy in the United States: Executive Summary,  The Health Inequality Project, April 2016, https://www.healthinequality.org/documents/paper/healthineq_summary.pdf 

[iv] NICHOLAS KRISTOF, How Do We Fix the Scandal That Is American Health Care? New York Times, https://www.nytimes.com/2023/08/16/opinion/health-care-life-expectancy-poverty.html?smid=em-share

[v] Life Expectancy at Birth by State, National Center for Health Statistics, https://www.cdc.gov/nchs/pressroom/sosmap/life_expectancy/life_expectancy.htm (cdc.gov)

[vi] Life Expectancy at Birth – Bangladesh, World Bank Group https://data.worldbank.org/indicator/SP.DYN.LE00.IN?locations=BD

[vii]Achievements in Public Health, 1900-1999: Healthier Mothers and Babies, Centers for Disease Control (CDC), Achievements in Public Health, 1900-1999: Healthier Mothers and Babies (cdc.gov)

[viii] NICHOLAS KRISTOF, How Do We Fix the Scandal That Is American Health Care? New York Times, https://www.nytimes.com/2023/08/16/opinion/health-care-life-expectancy-poverty.html?smid=em-share

[ix] Sandro Galea, Nason Maani, The Cost of Preventable Disease in the US,  The Lancet, October, 2020, https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(20)30204-8/fulltext

The post The Real Conversation We Should Be Having as the United States Pulls Out of the World Health Organization appeared first on Medika Life.

As parents you’ve been force fed a barrage of carefully scripted “justifications” for these vaccines and in case anyone considered an independent thought, legislation would simply be updated to include new vaccines, essentially removing your choice. In all States in the US a child cannot enter school without having complied with a vaccination schedule. Can you object? Yes, but only in certain states, and usually only on religious grounds. States like California are mandatory, no matter your objection.

The health impacts of the mandated 16 vaccines (spread over 72 doses, before the age of 18) have never enjoyed close scrutiny. What we do know for certain is that older adults (50+) who benefited from far fewer vaccines (3 on average), have far more resilient immune systems when compared to a 20 or 30 year old. Our immune system benefits from each challenge it receives, learning and growing stronger. By preventing many non-fatal infections through an expanded immunization agenda, we actively restrict our immune system from developing properly.

In short, we are producing weaker and less resilient human beings, one’s that are more prone to disease and more likely to develop chronic conditions.

Shockingly, a pre-licensing placebo-controlled safety study is not required in the US for the licensing of a vaccine. Don’t, however, take my word for it. THE HHS confirmed this in response to a written inquiry in 2018, the reply coming from Melinda Wharton, MD, MPH, then Acting Director of the National Vaccine Program Office. The question is shown below;

Please explain how HHS justifies licensing any pediatric vaccine without first
conducting a long-term clinical trial in which the rate of adverse reactions is
compared between the subject group and a control group receiving an inert
placebo?

Inert placebo controls are not required to understand the safety profile of a new vaccine, and are thus not required. In some cases, inclusion of placebo control groups is considered unethical. Even in the absence of a placebo, control groups can be useful in evaluating whether the incidence of a specific observed adverse event exceeds that which would be expected without administration of the new vaccine. Serious adverse events are always carefully evaluated by FDA to determine potential association with vaccination regardless of their rate of incidence in the control group. In cases where an active control is used, the adverse event profile of that control group is usually known and the findings of the study are reviewed in the context of that knowledge.

Decades of indoctrination and conditioning have convinced us that science never lies and that we cannot question anything produced by the scientific community. Science does not lie, not in a pure, unadulterated form. What we are bombarded with on a daily basis is, however, not any form of science any ethical professional would dare to claim. It is business, abetted by regulatory bodies and governments, masquerading behind and appropriating science, which is then twisted to suit the purposes of the companies benefiting from it.

Truth has become an outdated, antiquated word in the modern world of medical science.

You may ask, what this has to do with RFK, Jr., vaccines, and the medical fraternity?

You’ve recently participated in a global medical experiment with completely unknown consequences, at least none that are yet glaringly apparent, aside from a global increase in cancers, heart conditions and a litany of other other medical conditions, many of which can prove fatal. COVID “vaccines” were administered globally to billions of individuals. You may be one.

Almost all of your doctors and medical professionals, with a few exceptions, encouraged you to take these treatments. The billing that they were approved for broad use was misleading and the manner in which approval was obtained left much to be desired. These treatments were experimental, not adequately tested, and couldn’t remotely be called definitively safe. Why would your trusted healthcare providers do this?

Indoctrination is trusting a system of which they are the product. It no longer exists to foster only the best interest of the patients but rather leaves open the possibility of conflict of interest around “patient care or profit.” Most doctors didn’t even think to question the safety of the “miraculous Covid cure.”

A Global Pandemic

At the end of 2019, the world was exposed to a global contagion we were told was deadly, and much like influenza, in some instances it was. The source of the contagion has yet to be established, but facts seem to point at a Chinese research facility, a topic you can read more about here. Covid was to become a household word over the next two years, one that would dictate movement, work, schooling, and every other normal aspect of our lives as countries closed their borders, curfews were installed, and almost every aspect of our day-to-day life was dictated by our elected governments.

Two months after the outbreak, a miraculous breakthrough was announced: a vaccine! Based on a new technology, mRNA, the vaccine promised to reduce transmission and offer protection. We waited with bated breath, and in late November 2020, the vaccine was released for public use. After months of confinement, travel restrictions, working from home, and avoiding elderly members of our families, we sighed a global sigh of relief.

That sigh proved to be a little pre-emptive. Suddenly, taking the vaccine was no longer a matter of choice. It became mandated, and in many countries governments hid behind cloaks of restrictions rather than coming out and publicly mandating the Covid vaccine. Work, school and access to food and housing were subject to individuals being vaccinated. As I sit and type this, I still cannot believe how dystopian it sounds.

Billions had the vaccine administered, many not though choice, but through coercion. No vaccine, no work, no school, no food, and no access to rented property. In countries like Australia people refusing the vaccine, anti-vaxers, as they were quickly labeled, were even put into interment camps.

A Closer Look Behind mRNA and Pfizer and Moderna’s “Vaccines”

Why would people have refused to be injected with the Covid “vaccines” if they promised to protect you and reduce transmission? It turns out not everyone can be classified as a sheep. Questions were asked right from the outset of the announcement of the release of the vaccines.

It takes anywhere between six to 10 years to bring a vaccine to market. The reason for this is that the vaccine requires lengthy trials to prove safety. We know from experience that side effects can take years to manifest. Bringing a product to market in nine months raised huge flags.

We now know that some companies involved in producing what they loosely termed a “vaccine” to take advantage of market protection (in particular, Modena and BioNTech/and Pfizer) obscured data and omitted certain tests in the clinical trials of their Covid treatments. Tests that would have disclosed the reality of their treatments’ ability to integrate with our DNA, use of the SV-40 enhancer (a known link to cancer) in their treatments in levels far exceeding acceptable levels (clear clinical evidence of this vector has been found in the vaccines despite their continued denial) and effecting a bait and switch with the release of their final product, altered from the original provided for testing.

——–

——

Essentially, and we can debate why until time provides answers, these companies, in a global outbreak orchestrated by unknown players and enforced by your governments, forced an essentially untested, new type of gene therapy (not a vaccine) down your global throats, the full consequences of which have yet to become apparent. This quote is from an expert in the field of genomics (Kevin McKernan, who headed up the global genome project) on the mRNA vaccines.

These gene therapies are an attempt to centralize control over this evolutionary process, where they can mandate mRNA injections into billions of people and play SimCity on the evolutionary process and the human trajectory. They are entirely incapable of doing this and it is a disastrous idea. The hubris of authoritarians is an extinction level risk for humankind and needs to be dis-intermediated swiftly.

I have linked to a few articles in the paragraphs abovefor those with an interest in genomics, viruses, and vaccines. Two years ago, this article would have been labelled as anti-vaxer and dismissed. I sincerely hope we’ve moved beyond that point and that science is able to reclaim its integrity. This brings us back to RFK Jr. and America’s co-opted health care system.

The Perfect Pharma Salesman is…

Your doctor, of course. When you present yourself for medical assistance, you are in fact, facing a representative of the pharmaceutical industry. Doctors will argue vehemently against this, but the fact remains, their universities, courses, curricula, and anything relating to their degrees and the educations they receive is regulated by pharma. Doctors are the public face of a multi-billion dollar marketing scheme and pharma are the beneficiaries.

A doctor is indoctrinated from the first day they step into a class.

Little wonder then they would play along with the farce of the Covid “vaccines”, knowing full well mRNA was a new and as yet unproven delivery method (previously restricted to testing on end-of-life patients) for what was an untested and unsafe treatment. Established beliefs and conditioning often fly in the face of logic and common sense. Little wonder they played along. Indoctrination is a powerful tool.

This indoctrination extends to every aspect of modern medicine, including the ridiculous number of times your child (if you’re a US citizen) is vaccinated by the time they reach the age of 18. Don’t believe me? Read this advice from the CDC, and do make a note of how many times Pfizer and Moderna’s names appear (the same companies that just experimented on you). The question this begs, is why would we suddenly be vaccinating our children so heavily, so frequently, and with a such a dizzying array of shots.

H.R.5546 – National Childhood Vaccine Injury Act of 1986

The United States (in a moment of madness or more likely, successful lobbying) indemnified pharma companies to protect them against any possible legal claims arising from the use of a vaccine in children. In effect, this became a “get out of jail free” card that led directly to the frenzied development of “vaccines” for every imaginable disease under the sun. Once again, doctors were at the forefront of selling these treatments to their patients.

If you’ve been indoctrinated into the faith, it is sacrilege to question your god. In modern medicine, it is tantamount to self destruction. This indoctrination is the main obstacle Kennedy faces. Pharma’s influence permeates every level of modern healthcare, from politics to regulatory authorities such as the CDC and NIH and on, down to the doctors and nurses, the real face of modern medicine.

While many label Kennedy as anti-vaccine and a conspiracy theorist, this is simply a ruse to discredit him and evade examining the real and pertinent concerns he raises relating to the state of American healthcare. He has come up with an incredibly simple and elegant solution to the vaccine question.

Burning the “Get Out of Jail Free” Card

Remove the immunity enjoyed by pharma for childhood and other vaccines and sit back and wait to see how many pharma companies have actual faith in the products they are retailing. Expect to see the number of vaccinations your child currently endures reduced dramatically. Why? Simply because these products do carry risks, severe or otherwise, that have been obscured by companies in their haste to get a product to market. Make hay while the sun shines, as the expression goes, only in this instance it was profit rather than sunshine. Profit that was protected by the US government. Until now.

The topic of vaccines is an especially sensitive one, confounded by multiple factors when it should actually be governed by one simple question. Is the vaccine safe for your child? The truth is, we cannot be sure, except in the instance of mRNA based shots now touted for the market. These are fraught with hidden dangers and Kennedy’s removal of the blanket indemnity for these so called “vaccines” which are actually gene therapies, will no doubt result in their removal from the market.

The reason we cannot be sure is that the clinical trial system is as broken as the rest of healthcare, and is subject to the same manipulation and lobbying influences the rest of the healthcare system endures. Manipulation and subversion of data is common practice, the two most glaring public examples being the latest additions to the vaccine stable, namely Pfizer and Moderna’s Covid treatments.

Kennedy simply wants the truth to out. He wants to ensure your children are enjoying the protection they deserve and that the individuals playing medical roulette with their health are held to account. Convincing the devout (your doctors) of his intentions may be an insurmountable obstacle, unless we can bundle the lot on a donkey on the road to Damascus.

***

[Always consult with your physician to determine medical advice and direction. This article does not intend to suggest you should or should not receive vaccines according to a recommended schedule. It does recommend that you study peer-review science and ask informed questions.]

The post Kennedy’s Biggest Challenge Isn’t Vaccines, It’s Medical Indoctrination appeared first on Medika Life.

“First 100 days,” said Means, a former consultant to Big Pharma who uses the social platform X to focus attention on chronic disease. “What should be done to reform the FDA?”

The question was more than rhetorical. Means is among a cadre of health business leaders and nonmainstream doctors who are influencing President Donald Trump’s focus on health policy.

Trump’s return to the White House has given Means and others in this space significant clout in shaping the nascent health policies of the new administration and its federal agencies. It’s also giving newfound momentum to “Make America Healthy Again,” or MAHA, a controversial movement that challenges prevailing thinking on public health and chronic disease.

Its followers couch their ideals in phrases like “health freedom” and “true health.” Their stated causes are as diverse as revamping certain agricultural subsidies, firing National Institutes of Health employees, rethinking childhood vaccination schedules, and banning marketing of ultra-processed foods to children on TV.

Public health leaders say the emerging Trump administration’s interest in elevating the sometimes unorthodox concepts could be catastrophic, eroding decades of scientific progress while spurring a rise in preventable disease. They worry the administration’s support could weaken trust in public health agencies.

Georges Benjamin, executive director of the American Public Health Association, said he welcomes broad intellectual scientific discussion but is concerned that Trump will parrot untested and unproven public health ideas he hears as if they are fact.

Experience has shown that people with unproven ideas will have his ear and his “very large bully pulpit,” he said. “Because he’s president, people will believe he won’t say things that aren’t true. This president, he will.”

But those in the MAHA camp have a very different take. They say they have been maligned as dangerous for questioning the status quo. The election has given them an enormous opportunity to shape politics and policies, and they say they won’t undermine public health. Instead, they say, they will restore trust in federal health agencies that lost public support during the pandemic.

“It may be a brilliant strategy by the right,” said Peter McCullough, a cardiologist who has come under fire for saying covid-19 vaccines are unsafe. He was describing some of the election-season messaging that mainstreamed their perspectives. “The right was saying we care about medical and environmental issues. The left was pursuing abortion rights and a negative campaign on Trump. But everyone should care about health. Health should be apolitical.”

The movement is largely anti-regulatory and anti-big government, whether concerning raw milk or drug approvals, although implementing changes would require more regulation. Many of its concepts cross over to include ideas that have also been championed by some on the far left.

Robert F. Kennedy Jr., an anti-vaccine activist Trump has nominated to run the Department of Health and Human Services, has called for firing hundreds of people at the National Institutes of Health, removing fluoride from water, boosting federal support for psychedelic therapy, and loosening restrictions on raw milk, consumption of which can expose consumers to foodborne illness. Its sale has prompted federal raids on farms for not complying with food safety regulations.

Means has called for top-down changes at the U.S. Department of Agriculture, which he says has been co-opted by the food industry.

Though he himself is not trained in science or medicine, he has said people had almost no chance of dying of covid-19 if they were “metabolically healthy,” referring to eating, sleeping, exercise, and stress management habits, and has said that about 85% of deaths and health care costs in the U.S. are tied to preventable foodborne metabolic conditions.

A co-founder of Truemed, a company that helps consumers use pretax savings and reimbursement programs on supplements, sleep aids, and exercise equipment, Means says he has had conversations behind closed doors with dozens of members of Congress. He said he also helped bring RFK Jr. and Trump together. RFK Jr. endorsed Trump in August after ending his independent presidential campaign.

“I had this vision for a year, actually. It sounds very woo-woo, but I was in a sweat tent with him in Austin at a campaign event six months before, and I just had this strong vision of him standing with Trump,” Means said recently on the Joe Rogan Experience podcast.

The former self-described never-Trumper said that, after Trump’s first assassination attempt, he felt it was a powerful moment. Means called RFK Jr. and worked with conservative political commentator Tucker Carlson to connect him to the former president. Trump and RFK Jr. then had weeks of conversations about topics such as child obesity and causes of infertility, Means said.

“I really felt, and he felt, like this could be a realignment of American politics,” Means said.

He is joined in the effort by his sister, Casey Means, a Stanford University-trained doctor and co-author with her brother of “Good Energy,” a book about improving metabolic health. The duo has blamed Big Pharma and the agriculture industry for increasing rates of obesity, depression, and chronic health conditions in the country. They have also raised questions about vaccines.

“Yeah, I bet that one vaccine probably isn’t causing autism, but what about the 20 that they are getting before 18 months,” Casey Means said in the Joe Rogan podcast episode with her brother.

The movement, which challenges what its adherents call “the cult of science,” gained significant traction during the pandemic, fueled by a backlash against vaccine and mask mandates that flourished during the Biden administration. Many of its supporters say they gained followers who believed they had been misled on the effectiveness of covid-19 vaccines.

In July 2022, Deborah Birx, covid-19 response coordinator in Trump’s first administration, said on Fox News that “we overplayed the vaccines,” although she noted that they do work.

Anthony Fauci, who advised Trump during the pandemic, in December 2020 called the vaccines a game changer that could diminish covid-19 the way the polio vaccine did for that disease.

Eventually, though, it became evident that the shots don’t necessarily prevent transmission and the effectiveness of the booster wanes with time, which some conservatives say led to disillusionment that has driven interest in the health freedom movement.

Federal health officials say the rollout of the covid vaccine was a turning point in the pandemic and that the shots lessen the severity of the disease by teaching the immune system to recognize and fight the virus that causes it.

Postelection, some Trump allies such as Elon Musk have called for Fauci to be prosecuted. Fauci declined to comment.

Joe Grogan, a former director of the White House’s Domestic Policy Council and assistant to Trump, said conservatives have been trying to articulate why government control of health care is troublesome.

“Two things have happened. The government went totally overboard and lied about many things during covid and showed no compassion about people’s needs outside of covid,” he said. “RFK Jr. came along and articulated very simply that government control of health care can’t be trusted, and we’re spending money, and it isn’t making anyone healthier. In some instances, it may be making people sicker.”

The MAHA movement capitalizes on many of the nonconventional health concepts that have been darlings of the left, such as promoting organic foods and food as medicine. But in an environment of polarized politics, the growing prominence of leaders who challenge what they call the cult of science could lead to more public confusion and division, some health analysts say.

Jeffrey Singer, a surgeon and senior fellow at the Cato Institute, a libertarian public policy research group, said in a statement that he agrees with RFK Jr.’s focus on reevaluating the public health system. But he said it comes with risks.

“I am concerned that many of RFK Jr.’s claims about vaccine safety, environmental toxins, and food additives lack evidence, have stoked public fears, and contributed to a decline in childhood vaccination rates,” he said.

Measles vaccination among kindergartners in the U.S. dropped to 92.7% in the 2023-24 school year from 95.2% in the 2019-20 school year, according to the Centers for Disease Control and Prevention. The agency said that has left about 280,000 kindergartners at risk.

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

The post Make America Healthy Again: An Unconventional Movement That May Have Found Its Moment appeared first on Medika Life.

Perhaps the biggest wild card is Donald J. Trump’s return to the White House and the nomination of several candidates who have suggested that they will reinvent Health and Human Services, the Food and Drug Administration, Centers for Disease Control, and the Centers for Medicare and Medicaid Services—key agencies that set the agenda for public health and innovation.

The second unknown is the thin line separating misinformation from disinformation.  Historically, we looked to public health scientists to guide us.  Now, we are uncertain who to trust regarding health information.  Advice:  Do not rely on “X” as a fact-checking source – it’s merely noise.  But can you trust significant news sources, C-Suite execs, or elected officials?  It’s hard to say.  There is a vast divide between an honest mistake and willful deception. When it comes to health, do your homework – always!

A third factor must be included in the many 2024 health rankings and “Top 10” analyses that will appear in the days ahead. Our planet’s and people’s health are deeply intertwined. Rising temperatures, air pollution, and extreme weather events are not just environmental concerns but public health emergencies. These factors disproportionately impact vulnerable populations, exacerbating chronic conditions like asthma, cardiovascular disease, and mental health disorders. Addressing these challenges requires health professionals to embrace a broader perspective, recognizing that the fight for cleaner air, sustainable food systems, and resilient communities is inseparable from the mission to improve individual health outcomes.

Here are 10 health-sector developments—not ranked—to watch in the coming year, determined by media coverage, reader interest, and personal interest. These “10” could be Top Hundreds or Thousands. Happily, there were many advancements in 2024 to applaud. Yet, the pain points, too, are many. There are many publication lists to check – reviewing many is worthwhile. What is most important is to reflect on the needs of people and planet and commit to make a difference. The planet doesn’t need people. People need the planet. Equally so, people need each other.

This list’s topics were selected using data from global news outlets, academic publications, press releases, analytics platforms like Google Trends, and social media engagement metrics. While the list reflects the broad measure of public interest, it provides an overview of some of the positive and most worrisome health shifts and signals of what lies ahead.

1. AI-Powered Diagnostics Revolutionize Early Detection

Augmented implementation (AKA artificial intelligence) will redefine diagnostics in the years ahead. AI is poised to redefine diagnostics, with breakthroughs in the early detection of diseases like pancreatic cancer offering unprecedented accuracy and saving lives. Recent breakthroughs set the stage for broader adoption of AI in detecting other cancers and chronic diseases in 2025 and beyond, enticing the biopharma sector to interest in clinical trials to develop treatments for these deadly cancers.  This is a prime example of where AI can become a tipping point for earlier interventions and better patient outcomes globally.

2. India Leadership in Affordable Vaccine Development

India is quietly solidifying a reputation as the “pharmacy of the world” through several initiatives, such as launching a low-cost universal flu vaccine. Developed through a groundbreaking public-private partnership, this vaccine leverages advanced mRNA technology to provide broad-spectrum protection against multiple flu strains. By prioritizing affordability and accessibility, the initiative aims to protect millions of people in low- and middle-income countries, showcasing a scalable model for addressing global health inequities.

India has all the pieces to become a more significant player in the life science innovation puzzle – talent, scientific rigor, and an open-minded government willing to align its drug regulatory system with the world’s gold standard – the Food and Drug Administration.

India’s new rare disease center in New Delhi addresses critical global health gaps, setting a precedent for similar initiatives worldwide. Keep an eye on future developments from India to the world and investments from US-based life science companies in India’s strong talent base.

3. Breakthroughs in Alzheimer’s Disease Treatment

A novel gene-editing therapy targeting the APOE4 gene variant in the United States shows promise in addressing Alzheimer’s progression, and three new drugs were approved in the United Kingdom that may slow down memory decline in early Alzheimer’s disease. This continuing commitment by life science companies to invest in Alzheimer’s treatments after waves of disappointments could mark a turning point in one of the most vexing and worrisome neurodegenerative diseases.

Additionally, long-standing preventive disease pioneer Dean Ornish, MD, Founder and President of the Preventative Medicine Research Institute, has shown a possible pathway to reversing Alzheimer’s symptoms without medication. Ornish’s research on lifestyle interventions—emphasizing diet, exercise, and stress management—gained significant attention in 2024 and highlights the role of holistic approaches in improving cognitive health. His pathway does not dismiss using prescription medicine. Leading medical minds and consumers’ minds should take lifestyle medicine seriously.  It’s not the first time that Dr. Ornish has been proven right.

4. United Kingdom Moves Toward Digital Health Leadership

The United Kingdom launched a nationwide digital health initiative integrating wearable technology with its revered National Health Service (NHS). By enabling people to track chronic conditions like diabetes and hypertension in real-time, the initiative enhances patient engagement and accelerates preventive care delivery. Early results indicate improved patient outcomes and reduced hospital admissions. Looking ahead, 2025 could see the expansion of this initiative to include predictive analytics, further enhancing preventative care and patient empowerment.

UK Finance Minister/Chancellor Rachel Reeves announced in 2024 that the government is increasing the national health budget by US$29.33bn, a significant increase in NHS resourcing. Increased investment in infrastructure, technology and patient care position the United Kingdom as a launching point for new biomedical research and innovation waves.

5. Cancer Vaccines Gain Momentum

Personalized cancer vaccines emerged as a game-changing innovation in oncology. These vaccines train the immune system to target and destroy cancer cells based on the unique genetic mutations in an individual’s tumor, offering a highly tailored approach to treatment. A U.S.-based biotech company reported successful Phase 3 trial results for a melanoma vaccine, demonstrating significant reductions in recurrence rates.  

One promising example is the Moderna and Merck mRNA-based vaccine program for adjuvant treatment of high-risk melanoma. In Phase IIb results, the therapy showed a 44 percent lower risk of cancer recurrence or death compared to Merck blockbuster cancer drug Keytruda alone. Ongoing trials are exploring its efficacy in combating other cancers, such as lung and breast cancer. These are rigorous clinical programs with all the scientific peer-review requirements of a new medication.

6. America Begins to Take Serious Note of Obesity

The United States has finally begun to address obesity as a serious health concern. New policies and initiatives have been implemented to combat this epidemic, including improved access to nutrition education, increased funding for obesity research, and the development of innovative treatment options. Food and Drug Administration approval of new weight-loss GLP-1 drugs has sparked hope for more effective interventions. Additionally, public health campaigns have raised awareness about the long-term health risks associated with obesity, leading to a shift in societal attitudes and increased support for those struggling with weight management.

While weight-loss drugs offer promise, addressing obesity as a multifaceted health issue—spanning diabetes, heart disease, and more—remains critical. However, medications alone are not the miracle solution to the world’s weight problem. Will 2025 become the year of recognizing obesity as an umbrella disease?

7. Israeli Innovation –  Resilience Under Pressure

Sudden attacks from all directions would consume any nation’s emotional and physical energies. If so, the past 16 months should absolutely distract Israel – a country the size of New Jersey – and its nine million Jewish, Muslim, and Druze citizens – from anything other than self-defense.  Despite incredible challenges, Israel continues to innovate, with its 1,600 life science companies driving advancements in digital health, diagnostics, and bio-convergence. Israeli startups raised $2.43 billion in the third quarter of 2024 across 99 rounds, representing a 32 percent increase compared to the same period in 2023 (pre-October 2023)

The number of groundbreaking Israeli-developed medical devices, biologics, and information technologies incorporated into US-headquartered life science companies’ pipelines and product portfolios secures this nation’s position as a global innovator hub. Its role model hospital, Sheba Medical Center, ranks among the world’s top health systems and seamlessly integrates the country’s cutting-edge technologies in intensive care, telemedicine, early diagnostics, smart surgical equipment, and digital imaging throughout its system.

Israel is taking another leap in health innovation through its investment in bio-convergence. It is poised to play a significant role in the next technological wave of the 21st century. 

8. US Advances in Regenerative Medicine

Regenerative medicine focuses on repairing or replacing damaged tissues and organs, tapping into the body’s natural healing processes. Innovations like stem cell regeneration, cell therapy, diabetes and regenerative knee treatments offer alternatives to invasive surgeries and improve outcomes for chronic conditions.

Regulatory frameworks are crucial to this progress, providing clear guidelines and streamlined approval processes to ensure safety while fostering innovation. As regenerative medicine reshapes health delivery, it stands out as a transformative force in addressing some of the most pressing medical challenges. It is science fiction in many ways—maintain an open mind.

9. Global Antimicrobial Resistance Collaboration

The WHO’s global antimicrobial resistance network is a critical step in combating superbugs. It enables real-time data sharing to identify resistance patterns and drive new antibiotic development. It is a big deal. In a world where pathogens know no borders, collective action through such a network is essential to safeguarding the efficacy of treatments and protecting lives worldwide. The urgency has willing partners ready to engage.

This collaborative surveillance network is a big step forward in the response to a silent pandemic threatening global health. Coordinated action across nations equips health systems with real-time tools to identify and respond to resistance patterns. The rise of drug-resistant infections undermines decades of medical progress, turning treatable conditions into life-threatening challenges. A unified surveillance network enhances early detection and targeted interventions and drives the development of new antibiotics and stewardship programs.  Watch what happens in the coming year – our well-being is at stake.

10. A New White House Administration – Anxiety Versus Reality

As the second Trump administration prepares to take up residence in the White House, health ecosystem stakeholders are abuzz about potential policy shifts. Drawing from past actions and election campaign rhetoric, it’s anticipated that this administration – based on executive nominees such as Robert F. Kennedy, Jr., might implement changes through executive authority, bypassing congressional approval.  Food regulation policy is almost a given.  What about access to (some) vaccines? How about the review and regulations of medicines?  Verbal controversy leaves many wondering what will happen next.

The incoming administration’s health policy agenda remains uncertain, with potential changes to the ACA, Medicaid, and reproductive health policies sparking debate. Additionally, there may be moves to restrict access to abortion and contraception, reshape Medicaid through waivers and work requirements, and revise policies affecting LGBTQ+ health and immigration-related health needs.  The possibilities that can generate anxiety are numerous.  Wait and watch!

The Year Ahead and Beyond

These 10 health developments reflect the intersection of innovation, policy, and global collaboration. As we navigate 2025, the focus on improving lives and addressing disparities remains our collective responsibility – to rally to ideas and innovations that can improve people’s and our planet’s well-being.

From AI-supported diagnosis to vaccine breakthroughs in India and digital health leadership in the UK, the global health community demonstrates endless ingenuity. The developments of 2024 offer a roadmap for the future, proving that innovation is a team sport and together can overcome even the most formidable health challenges.

But innovation is like a Jenga structure—pull out the wrong piece at the wrong time, and health innovation can crumble or come to a screeching halt. It rests on three pillars: 1. People, 2. Policy, and 3. Investment. If policies do not support continued biomedical advances, equity and big business will likely search for other sectors that offer promise with a clear vision of a return on investment.

Let’s watch and advocate for a world where health in developed and emerging nations remains a top priority.

The post 2024 Health Trends: Progress, Challenges, and Opportunities appeared first on Medika Life.

Questionable parenting practices? Yeah. But our dinner conversations are amazing and spark the level of curiosity and appreciation in public health that I wish more people had, especially right now.

About three weeks ago, my kids saw that I was a little worried about something. Instead of telling them outright, I turned to our old game and asked them to tell me what they thought was the scariest disease.

Most people would go for Ebola because of its Hollywood-level freak out potential. Cholera is very scary as well, and an awful way to die. But my kids know by now that there’s one blue ribbon winner in my book when it comes to very scary diseases: Influenza.

Not garden-variety seasonal influenza. No, I’m talking about pandemic level influenza, like the 1918 pandemic flu that killed an estimated 50 million people and sickened a fifth of the world’s population.

This strain of influenza is the stuff of nightmares. A disease that spreads so rapidly that 2-3 healthy people could get infected by one sick person. A disease so deadly that it turns our own immune system against us, tricking it into a massive overreaction called a cytokine storm that either kills us or lays waste to our natural defenses so that that infections like bacterial pneumonia just waltz right into our bodies.

It’s why in 1918 the healthiest people often died the fastest: as in showing up for work in the morning and dead by night kind of fast. In places like Baltimore, Philadelphia, Seattle and countless corners of the world, the Great Influenza killed so quickly and debilitated people so widely that basic services broke down. In scenes reminiscent of Medieval times during the Bubonic Plague, when families were asked to bring out their dead, there were instances of bodies being stacked in the streets of America’s major cities.

And just like Bubonic Plague, where victims near death displayed the tell-tale, malodourous rash of “Ring around the Rosie” children’s song fame, care providers in 1918-19 watched as patients who were near death turned blue from oxygen failing to get through disease-ravaged lungs.

Here’s another little-known twist: Most people refer to the 1918-19 pandemic as the Spanish Influenza, assuming that was where it originated. But that’s not the case. Because of World War I, most of northern Europe was in a news blackout and didn’t report that thousands of soldiers engaged in fighting there were falling sick. Spain was the first European country to report on the emergence of the new disease, earning the unfortunate label as the epicenter for the pandemic.

There is general consensus among global health experts and historians that the true origin of the Spanish Influenza was likely thousands of miles away from Spain. It’s one of the many inconvenient truths that was glossed over in the midst of all the finger pointing and xenophobia directed to China during Covid-19: The deadliest plague in modern human history started just over a century ago not in a lab or a crowded urban tenement, but on a pig farm in the middle of Kansas, USA.

Which is why I’m watching the pigs now.

On October 29, the U.S. Department of Agriculture detected the first known transmission of H5N1 avian influenza to pigs on a small backyard farm in Oregon where poultry had been infected and euthanized recently. While certainly not a reason to panic, this milestone was alarming enough that I couldn’t disguise my concern during family dinner three weeks ago.

There are several reasons why we should all be keeping an eye on where H5N1 goes next.

First, think of pigs like a Vitamix for whirling around zoononic (animal) and human strains of influenza and spilling out the perfect pandemic-level smoothie. Because we share so much in common with pigs, genetically speaking, and because pork is such an integral part of the global diet, the potential for this animal species to serve as an efficient transmitter of deadly influenza strains is particularly high. This is worrisome, because H5N1 is very deadly to humans, carrying with it a 50+ percent fatality rate (compared to a roughly 1 percent case fatality ratio for Covid-19 among U.S. patients).

Second, if Americans are angry now about the price of eggs – which strangely no presidential candidate connected to mass chicken culls from H5N1 – just wait for the economic and food supply impact of broader infections among pig herds.

But most importantly, America’s public health system has been slow to track H5N1, ignoring important lessons from Covid-19 and downplaying the potential threat that could be on the horizon. There are broad concerns that surveillance has lagged and impacted flocks and herds are being undercounted. U.S. media attention has focused on the safety of the nation’s milk supply, which is interesting since pasteurization kills all viruses and bacteria (something to note for all of you raw milk drinkers out there). And there seems to be inexplicable foot dragging with our efforts to conduct and broadly share regular genetic sequencing of different H5N1 samples to understand how the virus may be mutating into a more virulent pathogen.

Instead of focusing on the infrastructure we have in place to detect a potential spillover of H5N1 to humans, we are poised to cut funding and resources needed to effectively track and contain outbreaks before they spread.

While pandemic fatigue is real and we can’t dismiss its influence on U.S. politics, economics or popular culture right now, we also cannot afford to leave our front door open when a virus with pandemic intentions is creeping around our yard.

Now is the time to review and publicly discuss the lessons learned from Covid-19 on surveillance, health system strengthening, rapid reporting and effective intra—government and public communications. We have more advanced technologies and biosecurity measures that we can leverage, as well as incentives to ensure livestock operators are not collateral damage in our war against disease. Lastly, we can’t afford to weaken routine immunization policies when they may be our first line of defense against a novel pathogen that overwhelms our health systems again.

By combining proactive policies with strong communication strategies, including more effective ways to engage and educate the media, we can effectively prevent and manage the threat posed by H5N1 and other pandemic influenza viruses, safeguarding public health and minimizing economic disruptions.

The question is whether there is enough political will remaining after Covid to keep our guard up against pandemic threats, either homegrown in the U.S. or originating in a far-off hot zone. The answer is what keeps me up at night.

The post Watching the Pigs appeared first on Medika Life.

Panellists included Marion Gruber from IAVI, Marco Cavaleri from the European Medicines Agency, Hanna Nohynek from the National Institute for Health and Welfare, and Thomas Waite, the UK’s Deputy Chief Medical Officer. Through rich discussion, the panel underscored the importance of transparency, innovation, and public engagement in fostering vaccine confidence and uptake.

Misinformation and Trust in Vaccination

The conversation opened with Marco Cavaleri, who was reflecting on lessons from COVID-19. “To increase vaccine uptake, we need to rebuild trust,” he stated, adding that misinformation spread rapidly during the pandemic, leaving an “unfortunate, traumatic impact on public perception.” Cavaleri emphasised the role of regulators and public health authorities in maintaining “transparency about scientific data” and advocated engaging directly with citizens through modern communication channels, particularly social media, to counter misinformation.

Echoing this, Thomas Waite observed that while misinformation could be corrected through transparent education, disinformation posed a unique challenge due to its intentionally deceptive nature. “Engaging with disinformation on its terms is counterproductive,” he said, urging a clear communication approach firmly grounded in accurate, science-based information.

Transparency and Data Quality

Transparency emerged as a central pillar, with panellists stressing that open data and easy access to vaccination information play a vital role in public confidence. Hanna Nohynek spoke of Finland’s experience during COVID-19, where adverse events were reported in real time. This allowed the public to “see transparency in action,” building a stronger foundation of trust. Waite highlighted a similar approach in the UK, noting that the UK Health Security Agency’s data dashboard became a heavily used public resource, promoting transparency and providing real-time flu, RSV, and COVID-19 vaccination statistics.

Innovation and Access: Meeting New Vaccine Demands

The global vaccine pipeline is evolving rapidly, with innovations designed to address threats like respiratory diseases, antimicrobial resistance, and climate-related health impacts. Gruber remarked, “We are seeing new infectious diseases entering the northern hemisphere due to climate change, adding urgency to our need for innovative vaccines.” The conversation also spotlighted AMR (antimicrobial resistance), with Gruber discussing the advanced stages of tuberculosis vaccines. “AMR vaccines could be transformative in curbing resistance,” she added.

This innovation surge, however, brings challenges of its own. Waite noted that in the UK, “The immunisation schedule has become significantly more complex.” With the increase in adult vaccinations, including RSV, flu, shingles, and COVID-19, the programme now requires substantial public outreach to explain why vaccination remains crucial at each life stage. Gruber and Nohynek stressed that effective public engagement and education are essential to ensure uptake keeps pace with scientific advancements.

Bridging Health Inequities: Expanding Vaccine Access

Discussing global disparities, Nohynek raised the importance of equitable vaccine access, particularly for low- and middle-income countries. As she explained, the WHO’s Strategic Advisory Group of Experts (SAGE) has prioritised maternal vaccination for RSV in these regions. However, she pointed out gaps in clinical trials across continents, noting, “The absence of data from Asia, especially given high prematurity rates, underscores the need for global representation in trials.”

Gruber cited Argentina’s success with maternal RSV vaccinations as a promising case study. Argentina’s approach — a blend of government support, accessible vaccination points, and educational outreach — yielded 57% coverage in the first season. “Political will and cross-sector collaboration were key to this success,” she said, adding that lessons from Argentina could be instrumental as RSV vaccines roll out across Africa.

Economic Challenges and Prioritisation

Sibilia Quilici closed the panel by addressing the economic dimension of vaccine rollout. She argued for an economic perspective on immunisation, explaining that “vaccination is not just a health intervention but a key driver of societal and economic growth.” Nohynek highlighted the challenges her institution in Finland faces due to budget cuts, which she described as “counterproductive,” noting that restrictions on funding can hamper efforts to evaluate and introduce new vaccines effectively.

Cavaleri reinforced the need for a streamlined approach, remarking, “We need to integrate the vaccine approval process with recommendation systems to reduce the lag time. Six years from authorisation to patient arms is simply too long.”

The Path Forward: Building Resilient Immunisation Systems

The panel concluded with a unified call for increased transparency, streamlined regulatory frameworks, and sustained investment in vaccination programmes. Waite summarised the vision: “Advances in technology should make it easier for citizens to get vaccinated while service providers adapt to meet the needs of modern lifestyles.” Gruber echoed his sentiment, noting that “infections affect us all,” underscoring the importance of making vaccines accessible across diverse populations.

The panel’s insights ultimately emphasised that immunisation strategies must adapt to sustain progress, integrating public trust, technological advancements, and economic considerations. The panellists agreed that by addressing the challenges head-on, we can ensure vaccines continue to protect and empower communities globally.

The post Vaccines and Public Trust: Insights from the World Vaccine Congress Panel appeared first on Medika Life.